Prescription RequiredEnzalutamide 160 mg (Glenza) is an anti-androgen medicine used to treat prostate cancer, including advanced and metastatic forms of the disease. It works by blocking the effects of male hormones (androgens) that help prostate cancer cells grow. This helps slow cancer progression and may improve survival and quality of life. It should be taken only under the supervision of an oncologist.
| Generic name | Enzalutamide |
| Strength | 160 mg |
| Manufacturer | Glenmark |
| Package size | 28 Tablets |
| Used for | Prostate cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Enzalutamide is an androgen receptor inhibitor. It blocks the action of testosterone and other male hormones that stimulate prostate cancer cells. By preventing these hormones from activating cancer cells, it slows their growth and spread.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.
